Brief: AB Science Granted Authorization By ANSM To Initiate Confirmatory Phase III Trial Of Masitinib In Progressive Forms Of Multiple Sclerosis

AB Science SA

03/01/2022 17:19

Jan 3 (Reuters) - AB Science SA  ABS.PA :
    * GRANTED AUTHORIZATION TO INITIATE CONFIRMATORY PHASE III
TRIAL
OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS BY THE
FRENCH HEALTH AUTHORITY (ANSM)
    * STUDY WILL ENROLL 800 PATIENTS FROM NUMEROUS STUDY CENTERS
    * PRIMARY OBJECTIVE OF STUDY WILL BE TO EVALUATE EFFECT OF
MASITINIB ON TIME TO CONFIRMED DISABILITY PROGRESSION

Source text for Eikon:  ID:nGNE82mvvR 
Further company coverage:  ABS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))